Research outputs
Selected research outputs
- The global prevalence of hepatitis D virus infection: systematic review and meta-analysis (Journal article - 2020)
- Liver fibrosis by transient elastography and virologic outcomes after introduction of tenofovir in lamivudine-experienced adults with HIV and hepatitis B virus (HBV) co-infection in Ghana (Journal article - 2015)
- Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor–Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis (Journal article - 2018)
- Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis (Journal article - 2017)
- Hepatitis B vaccination impact and the unmet need for antiviral treatment in Blantyre, Malawi (Journal article - 2022)
- Late presentation of hepatocellular carcinoma highlights the need for a public health programme to eliminate hepatitis B (Journal article - 2021)
2026
Launch of the Africa CDC toolkit for hepatitis B: bringing care closer to people in Africa.
Stockdale, A. J., Ndow, G., Adda, D., Tak, S., Johannessen, A., Spearman, C. W., & Africa CDC group of experts. (2026). Launch of the Africa CDC toolkit for hepatitis B: bringing care closer to people in Africa.. The lancet. Gastroenterology & hepatology, S2468-1253(26)00221-9. doi:10.1016/s2468-1253(26)00221-9
Africa must not be left out of the hepatitis B cure era.
El-Kassas, M., Shousha, H., Johannessen, A., & Hepatitis B in Africa Collaborative Network (HEPSANET). (2026). Africa must not be left out of the hepatitis B cure era.. The lancet. Gastroenterology & hepatology, 11(5), 349-350. doi:10.1016/s2468-1253(26)00024-5
Comorbid hepatic steatosis among people with HBV monoinfection and HBV/HIV coinfection in the hepatitis B in Africa collaborative network (HEPSANET): prevalence, predictors, and association with fibrosis
Chabala, F., Sinkala, E., Hamusonde, K., Brennan, A., Goss, A., Lamin, B., . . . Vinikoor, M. (2026). Comorbid hepatic steatosis among people with HBV monoinfection and HBV/HIV coinfection in the hepatitis B in Africa collaborative network (HEPSANET): prevalence, predictors, and association with fibrosis. In JOURNAL OF HEPATOLOGY Vol. 84 (pp. S926-S927). Retrieved from https://www.webofscience.com/
FRI-588-YI Real-world effectiveness of antiviral therapy for chronic HBV infection in Africa: HEPSANET analysis
Bheemraj, K., Guingané, A. N., Sombie, R., El-Kassas, M., Afihene, M., Okeke, E., . . . Johannessen, A. (2026). FRI-588-YI Real-world effectiveness of antiviral therapy for chronic HBV infection in Africa: HEPSANET analysis. Journal of Hepatology, 84, s940. doi:10.1016/s0168-8278(26)02487-6
Real-world effectiveness of antiviral therapy for chronic HBV infection in Africa: HEPSANET analysis
Bheemraj, K., Guingane, A. N., Sombie, R., El-Kassas, M., Afihene, M., Okeke, E., . . . Johannessen, A. (2026). Real-world effectiveness of antiviral therapy for chronic HBV infection in Africa: HEPSANET analysis. In JOURNAL OF HEPATOLOGY Vol. 84 (pp. S940). Retrieved from https://www.webofscience.com/
SAT-569 Variation in hepatitis B virus replication across Africa: analysis of the multicenter hepatitis B in Africa collaborative network (HEPSANET) cohort study
Bheemraj, K., De Vos, J., Guingané, A. N., Sombie, R., El-Kassas, M., Afihene, M., . . . Vinikoor, M. (2026). SAT-569 Variation in hepatitis B virus replication across Africa: analysis of the multicenter hepatitis B in Africa collaborative network (HEPSANET) cohort study. Journal of Hepatology, 84, s905. doi:10.1016/s0168-8278(26)02417-7
SAT-624 Comorbid hepatic steatosis among people with HBV monoinfection and HBV/HIV coinfection in the hepatitis B in Africa collaborative network (HEPSANET): prevalence, predictors, and association with fibrosis
Chabala, F., Sinkala, E., Hamusonde, K., Brennan, A., Goss, A., Lamin, B., . . . Vinikoor, M. (2026). SAT-624 Comorbid hepatic steatosis among people with HBV monoinfection and HBV/HIV coinfection in the hepatitis B in Africa collaborative network (HEPSANET): prevalence, predictors, and association with fibrosis. Journal of Hepatology, 84, s926-s927. doi:10.1016/s0168-8278(26)02463-3
Variation in hepatitis B virus replication across Africa: analysis of the multicenter hepatitis B in Africa collaborative network (HEPSANET) cohort study
Bheemraj, K., De Vos, J., Guingane, A. N., Sombie, R., El-Kassas, M., Afihene, M., . . . Vinikoor, M. (2026). Variation in hepatitis B virus replication across Africa: analysis of the multicenter hepatitis B in Africa collaborative network (HEPSANET) cohort study. In JOURNAL OF HEPATOLOGY Vol. 84 (pp. S905). Retrieved from https://www.webofscience.com/
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani, O., Abbas, A., Abbas, F., Abbas, K., Abbas, M., Abbasi, J., . . . Adjepong, P. (2026). Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Infectious Diseases, 26(1), 34-45. doi:10.1016/S1473-3099(25)00361-5
2025
Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case-control study
Stockdale, A. J., Kreuels, B., Shawa, I. T., Silungwe, N. M., Mbale, B., Chetcuti, K., . . . Gordon, M. A. (2025). Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case-control study. LANCET GLOBAL HEALTH, 13(11), e1924-e1934. Retrieved from https://www.webofscience.com/
Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines
Campbell, C., Wang, T., Stockdale, A. J., Todd, S., Jaworski, J., Glampson, B., . . . Matthews, P. C. (2025). Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines. JOURNAL OF VIRAL HEPATITIS, 32(11), 14 pages. doi:10.1111/jvh.70098
Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysis
Stockdale, A. J., Holt, B., Bhadoria, A. S., Sadasivan, A., Ikeda, D., Pollack, T., . . . Easterbrook, P. (2025). Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysis. LANCET GASTROENTEROLOGY & HEPATOLOGY, 10(11), 1013-1027. doi:10.1016/S2468-1253(25)00163-3
Treatment of chronic hepatitis B in Ethiopia: 1-year results from a real-life, multicentre, prospective cohort study
Rossvoll, L., Desalegn, H., Gudissa, F. G., Birhanu, D., Hussen, A., Cheneke, W., . . . Johannessen, A. (2025). Treatment of chronic hepatitis B in Ethiopia: 1-year results from a real-life, multicentre, prospective cohort study. Lancet Global Health, 13(11), e1914-e1923. doi:10.1016/S2214-109X(25)00309-2
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2025). LANCET INFECTIOUS DISEASES, 25(9), 1000-1010. doi:10.1016/S1473-3099(25)00093-3
Clinical Trials for Hepatitis Delta Virus in the WHO African region: A neglected virus among neglected viruses
Delphin, M., Campbell, J., Verrier, E. R., Anderson, M., Sukali, G., Maponga, T., . . . Matthews, P. C. (2025). Clinical trials for Hepatitis Delta Virus in the WHO African region: A neglected virus among neglected viruses. JOURNAL OF INFECTION, 91(1), 6 pages. doi:10.1016/j.jinf.2025.106514
A large multicentre hepatitis B cohort study in the United Kingdom highlights high rates of comorbidity associated with liver disease outcomes
Wang, T., Kim, Y. J., Jaworski, J., Glampson, B., Papadimitriou, D., Mayer, E., . . . Barnes, E. (2025). A large multicentre hepatitis B cohort study in the United Kingdom highlights high rates of comorbidity associated with liver disease outcomes. In JOURNAL OF HEPATOLOGY Vol. 82 (pp. 2 pages). Retrieved from https://www.webofscience.com/
Liver stiffness and AST-to-platelet ratio index (APRI) predict all-cause mortality in untreated people living with hepatitis B across Africa: a multi-centre cohort analysis in the hepatitis B in Africa collaborative network (HEPSANET)
Stockdale, A., Hamusonde, K., Lamin, B., Samateh, Y., Vinikoor, M., Afihene, M., . . . Johannessen, A. (2025). Liver stiffness and AST-to-platelet ratio index (APRI) predict all-cause mortality in untreated people living with hepatitis B across Africa: a multi-centre cohort analysis in the hepatitis B in Africa collaborative network (HEPSANET). In JOURNAL OF HEPATOLOGY Vol. 82 (pp. 2 pages). Retrieved from https://www.webofscience.com/
Preventing vertical transmission of HBV in LMICs: what could HBcrAg rapid tests add?
Stockdale, A., & Adda, D. (2025). Preventing vertical transmission of HBV in LMICs: what could HBcrAg rapid tests add?. LANCET GASTROENTEROLOGY & HEPATOLOGY, 10(5), 405-406. doi:10.1016/S2468-1253(25)00057-3
Validation of hepatocellular carcinoma risk scoring tools inpatients with chronic hepatitis B virus and hepatitis C virusinfection-results from a large multicentre cohort study
Kim, Y. J., Wang, T., Davis, C., Heinson, A. I., George, M., Borca, F., . . . Khakoo, S. I. (2025). Validation of hepatocellular carcinoma risk scoring tools inpatients with chronic hepatitis B virus and hepatitis C virusinfection-results from a large multicentre cohort study. In JOURNAL OF HEPATOLOGY Vol. 82 (pp. 2 pages). Retrieved from https://www.webofscience.com/
WED-006 Liver stiffness and AST-to-platelet ratio index (APRI) predict all- cause mortality in untreated people living with hepatitis B across Africa: a multi-centre cohort analysis in the hepatitis B in Africa collaborative network (HEPSANET)
Stockdale, A., Hamusonde, K., Lamin, B., Samateh, Y., Vinikoor, M., Afihene, M., . . . Johannessen, A. (2025). WED-006 Liver stiffness and AST-to-platelet ratio index (APRI) predict all- cause mortality in untreated people living with hepatitis B across Africa: a multi-centre cohort analysis in the hepatitis B in Africa collaborative network (HEPSANET). Journal of Hepatology, 82, s685. doi:10.1016/s0168-8278(25)01814-8
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Abani, O., Abbas, A., Abbas, F., Abbas, J., Abbas, K., Abbas, M., . . . Adjepong, P. (2025). Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Eclinicalmedicine, 81. doi:10.1016/j.eclinm.2025.103080
Distinct virologic trajectories in chronic hepatitis B patients identify heterogeneity in response to nucleotide analogue therapy
Wang, T., Campbell, C., Roadknight, G., Little, S., Stockdale, A., Todd, S., . . . Barnes, E. (2025). Distinct virologic trajectories in chronic hepatitis B patients identify heterogeneity in response to nucleotide analogue therapy. Journal of Hepatology, 78, S1075-S1076. doi:10.1016/j.jhepr.2024.101229
Epidemiology of hepatitis B and C viruses among pregnant women at Queen Elizabeth Central Hospital (QECH), Blantyre Malawi
Nkhata, C. B., Stockdale, A. J., Mvula, M. N., Kalongonda, M. M., Masamba, M., & Shawa, I. T. (2025). Epidemiology of hepatitis B and C viruses among pregnant women at Queen Elizabeth Central Hospital (QECH), Blantyre Malawi. MALAWI MEDICAL JOURNAL, 37(4), 211-215. doi:10.4314/mmj.v37i4.2
2024
Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos/tide analogue therapy
Wang, T., Campbell, C., Stockdale, A. J., Todd, S., McIntyre, K., Frankland, A., . . . Matthews, P. C. (2024). Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos/tide analogue therapy. JHEP Reports, 101229. doi:10.1016/j.jhepr.2024.101229
Machine learning can improve prediction of hepatitis B surface antigen seroclearance: A large multicentre cohort study in the United Kingdom
Wang, T., Jaworski, J., Glampson, B., Papadimitriou, D., Mercuri, L., Jones, C. R., . . . Barnes, E. (2024). Machine learning can improve prediction of hepatitis B surface antigen seroclearance: A large multicentre cohort study in the United Kingdom. In JOURNAL OF HEPATOLOGY Vol. 80 (pp. S759-S760). Retrieved from https://www.webofscience.com/
Retrospective analysis of longitudinal data for UK adults living with chronic HBV: characteristics of the population on dual therapy
Tan, C., Wang, T., Jaworski, J., Glampson, B., Papadimitriou, D., Mercuri, L., . . . Matthews, P. C. (2024). Retrospective analysis of longitudinal data for UK adults living with chronic HBV: characteristics of the population on dual therapy. In JOURNAL OF HEPATOLOGY Vol. 80 (pp. S676-S677). Retrieved from https://www.webofscience.com/
TOP-417 Machine learning can improve prediction of hepatitis B surface antigen seroclearance: A large multicentre cohort study in the United Kingdom
Wang, T., Jaworski, J., Glampson, B., Papadimitriou, D., Mercuri, L., Jones, C. R., . . . Barnes, E. (2024). TOP-417 Machine learning can improve prediction of hepatitis B surface antigen seroclearance: A large multicentre cohort study in the United Kingdom. Journal of Hepatology, 80, s759-s760. doi:10.1016/s0168-8278(24)02127-5
WED-471 Retrospective analysis of longitudinal data for UK adults living with chronic HBV: characteristics of the population on dual therapy
Tan, C., Wang, T., Jaworski, J., Glampson, B., Papadimitriou, D., Mercuri, L., . . . CMatthews, P. (2024). WED-471 Retrospective analysis of longitudinal data for UK adults living with chronic HBV: characteristics of the population on dual therapy. Journal of Hepatology, 80, s676-s677. doi:10.1016/s0168-8278(24)01937-8
HDV RNA and liver disease progression: What do we know?
Stockdale, A. J., & Degasperi, E. (2024). HDV RNA and liver disease progression: What do we know?. HEPATOLOGY, 79(5), 983-985. doi:10.1097/HEP.0000000000000663
HDV RNA and liver disease progression: What do we know? (Dec 29, 10.1097/HEP.0000000000000663, 2023)
Stockdale, A. J., & Degasperi, E. (2024). HDV RNA and liver disease progression: What do we know? (Dec 29, 10.1097/HEP.0000000000000663, 2023). HEPATOLOGY, 79(5), E149. doi:10.1097/HEP.0000000000000809
Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study
Minier, N., Guingane, A. N., Okeke, E., Sinkala, E., Johannessen, A., Andersson, M. I., . . . Sombie, R. (2024). Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study. LANCET GASTROENTEROLOGY & HEPATOLOGY, 9(4), 323-332. doi:10.1016/S2468-1253(23)00449-1
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Peto, L., Staplin, N., Campbell, M., Pessoa-Amorim, G., Mafham, M., . . . Landray, M. J. (2024). Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. NATURE COMMUNICATIONS, 15(1), 13 pages. doi:10.1038/s41467-023-43644-x
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. (2024). Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.. The Lancet. Child & adolescent health, S2352-4642(23)00316-4. doi:10.1016/s2352-4642(23)00316-4
2023
A new approach to prevent, diagnose, and treat hepatitis B in Africa
Spearman, C. W., Andersson, M. I., Bright, B., Davwar, P. M., Desalegn, H., Guingane, A. N., . . . Sonderup, M. (2023). A new approach to prevent, diagnose, and treat hepatitis B in Africa. BMC Global and Public Health, 1(1). doi:10.1186/s44263-023-00026-1
Aetiology and outcomes of cirrhosis and hepatocellular carcinoma in Blantyre, Malawi: Observational case-control and cohort study
Kreuels, B., Stockdale, A., Shawa, I., Silungwe, N., Chetcuti, K., Finch, P., . . . Gordon, M. (2023). Aetiology and outcomes of cirrhosis and hepatocellular carcinoma in Blantyre, Malawi: Observational case-control and cohort study. In TROPICAL MEDICINE & INTERNATIONAL HEALTH Vol. 28 (pp. 205). Retrieved from https://www.webofscience.com/
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. (2023). Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.. The lancet. Diabetes & endocrinology, S2213-8587(23)00253-X. doi:10.1016/s2213-8587(23)00253-x
MODELS OF CARE OF PEOPLE LIVING WITH CHRONIC HEPATITIS B: SYSTEMATIC REVIEW AND META-ANALYSIS
Stockdale, A. J., Holt, B., Bhadoria, A., Ikeda, D., Duong, D., Pollack, T., . . . Easterbrook, P. (2023). MODELS OF CARE OF PEOPLE LIVING WITH CHRONIC HEPATITIS B: SYSTEMATIC REVIEW AND META-ANALYSIS. In HEPATOLOGY Vol. 78 (pp. S1714-S1715). Retrieved from https://www.webofscience.com/
The Liver Meeting: Boston, Massachusetts Nov 10-14, 2023.
The Liver Meeting: Boston, Massachusetts Nov 10-14, 2023. (2023). In Hepatology (Baltimore, Md.) Vol. 78 (pp. S1-S2154). doi:10.1097/hep.0000000000000580
Aetiology and outcomes of cirrhosis and hepatocellular carcinoma in Blantyre, Malawi
Stockdale, A., Kreuels, B., Shawa, I., Silungwe, N., Chetcuti, K., Joekes, E., . . . Gordon, M. (2023). Aetiology and outcomes of cirrhosis and hepatocellular carcinoma in Blantyre, Malawi. In Journal of Hepatology Vol. 71 (pp. S522-S523). Vienna, Austria: Elsevier. doi:10.1016/S0168-8278(23)01279-5
Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workers
Isa, Y. S., Sicsic, J., Njuguna, H., Ward, J., Chakroun, M., El-Kassas, M., . . . Shimakawa, Y. (2023). Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workers. BMC MEDICINE, 21(1), 11 pages. doi:10.1186/s12916-023-02939-y
Aetiology and outcomes of cirrhosis and hepatocellular carcinoma in Blantyre, Malawi
Stockdale, A., Kreuels, B., Shawa, I., Silungwe, N., Chetcuti, K., Joekes, E., . . . Gordon, M. (2023). Aetiology and outcomes of cirrhosis and hepatocellular carcinoma in Blantyre, Malawi. In GUT Vol. 72 (pp. A62-A63). doi:10.1136/gutjnl-2023-BSG.106
Driving improvements in hepatitis B care in Africa: profile of the hepatitis B in Africa collaborative network (HEPSANET)
Riches, N., Vinikoor, M., Guingane, A. N., Johannessen, A., Lemoine, M., Matthews, P., . . . Spearman, W. (2023). Driving improvements in hepatitis B care in Africa: profile of the hepatitis B in Africa collaborative network (HEPSANET). JOURNAL OF HEPATOLOGY, 78, S1117-S1118. Retrieved from https://www.webofscience.com/
Simple treatment eligibility score for chronic HBV infection at peripheral health facilities in sub-Saharan Africa
Minier, N., Johannessen, A., Guingane, A., Wandeler, G., Vinikoor, M., Taljaard, J., . . . Shimakawa, Y. (2023). Simple treatment eligibility score for chronic HBV infection at peripheral health facilities in sub-Saharan Africa. JOURNAL OF HEPATOLOGY, 78, S916. Retrieved from https://www.webofscience.com/
The chiwindi study: results from a community-based hepatitis B serosurvey in Karonga, Malawi
Riches, N., Njawala, T., Thom, N., Mkandawire, C., Mzumara, W., Phiri, F., . . . Nkoka, O. (2023). The chiwindi study: results from a community-based hepatitis B serosurvey in Karonga, Malawi. In GUT Vol. 72 (pp. A57-A58). doi:10.1136/gutjnl-2023-BSG.96
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Emberson, J. R., Basnyat, B., Campbell, M., Peto, L., Pessoa-Amorim, G., . . . Landray, M. J. (2023). Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. LANCET, 401(10387), 1499-1507. doi:10.1016/S0140-6736(23)00510-X
Hepatitis B in Africa Collaborative Network: cohort profile and analysis of baseline data
Riches, N., Vinikoor, M., Guingane, A., Johannessen, A., Lemoine, M., Matthews, P., . . . Spearman, C. W. (2023). Hepatitis B in Africa Collaborative Network: cohort profile and analysis of baseline data. EPIDEMIOLOGY & INFECTION, 151, 10 pages. doi:10.1017/S095026882300050X
Cohort Profile: The National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) research dataset
Wang, T., Smith, D. A., Campbell, C., Freeman, O., Moysova, Z., Noble, T., . . . Matthews, P. C. (2023). Cohort Profile: The National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) research dataset. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 52(1), e27-e37. doi:10.1093/ije/dyac127
Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa
Johannessen, A., Stockdale, A. J., Henrion, M. Y. R., Okeke, E., Seydi, M., Wandeler, G., . . . Lemoine, M. (2023). Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa. NATURE COMMUNICATIONS, 14(1), 12 pages. doi:10.1038/s41467-022-35729-w
Chapter 11 Hepatitis D
Stockdale, A. J. (2023). Chapter 11 Hepatitis D. In Comprehensive Guide to Hepatitis Advances (pp. 281-307). Elsevier. doi:10.1016/b978-0-323-98368-6.00027-6
Hepatitis D
Stockdale, A. J. (2023). Hepatitis D. In Comprehensive Guide to Hepatitis Advances (pp. 281-307). doi:10.1016/B978-0-323-98368-6.00027-6
2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Wysocki, O., Zhou, C., Rogado, J., Huddar, P., Shotton, R., Tivey, A., . . . Co-Care, E. S. M. O. (2022). An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves. Cancers, 14(16). doi:10.3390/cancers14163931
Hepatitis B vaccination impact and the unmet need for antiviral treatment in Blantyre, Malawi
Stockdale, A. J., Meiring, J. E., Shawa, I. T., Thindwa, D., Silungwe, N. M., Mbewe, M., . . . Gordon, M. A. (2022). Hepatitis B Vaccination Impact and the Unmet Need for Antiviral Treatment in Blantyre, Malawi. JOURNAL OF INFECTIOUS DISEASES, 226(5), 871-880. doi:10.1093/infdis/jiab562
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Horby, P. W., Emberson, J. R., Mafham, M., Campbell, M., Peto, L., Pessoa-Amorim, G., . . . Landray, M. J. (2022). Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. LANCET, 400(10349), 359-368. doi:10.1016/S0140-6736(22)01109-6
Diagnostic performance of non-invasive liver fibrosis biomarkers: a bayesian individual patient data meta-analysis of hepatitis B cohorts in sub-saharan Africa (HEPSANET)
Stockdale, A., Johannessen, A., Henrion, M., Okeke, E., Seydi, M., Wandeler, G., . . . Lemoine, M. (2022). Diagnostic performance of non-invasive liver fibrosis biomarkers: a bayesian individual patient data meta-analysis of hepatitis B cohorts in sub-saharan Africa (HEPSANET). In JOURNAL OF HEPATOLOGY Vol. 77 (pp. S23-S24). Retrieved from https://www.webofscience.com/
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.
Lee, R. J., Wysocki, O., Zhou, C., Shotton, R., Tivey, A., Lever, L., . . . Armstrong, A. C. (2022). Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.. JCO clinical cancer informatics, 6, e2100177. doi:10.1200/cci.21.00177
A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi suggests an historic mechanism of transmission
Stockdale, A., Kreuels, B., Shawa, I. T., Meiring, J., Thindwa, D., Silungwe, N., . . . Gordon, M. (2021). A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi suggests an historic mechanism of transmission. In JOURNAL OF HEPATOLOGY Vol. 75 (pp. S670-S671). doi:10.1016/S0168-8278(21)01842-0
Diagnostic performance of non-invasive fibrosis markers for chronic hepatitis B in sub-Saharan Africa: a Bayesian individual patient data meta-analysis
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Mafham, M., Peto, L., Campbell, M., Pessoa-Amorim, G., Spata, E., . . . Landray, M. J. (2022). Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. LANCET, 399(10325), 665-676. doi:10.1016/S0140-6736(22)00163-5
Cause of hypereosinophilia shows itself after 6 years: Loa loa
Hicks, S. R., O'Dempsey, T., Khoyratty, F., Gupta, A., Stockdale, A., Beadsworth, M., . . . Slack, I. (2022). Cause of hypereosinophilia shows itself after 6 years: <i>Loa loa</i>. LANCET, 399(10323), E2. doi:10.1016/S0140-6736(21)02723-9
A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmission
Stockdale, A. (2022). A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmission. Journal of Viral Hepatitis. doi:10.1111/jvh.13646
Longer than 2 hours to antibiotics is associated with doubling of mortality in a multinational community-acquired bacterial meningitis cohort
Eisen, D. P., Hamilton, E., Bodilsen, J., Koster-Rasmussen, R., Stockdale, A. J., Miner, J., . . . Adegboye, O. A. (2022). Longer than 2 hours to antibiotics is associated with doubling of mortality in a multinational community-acquired bacterial meningitis cohort. SCIENTIFIC REPORTS, 12(1), 11 pages. doi:10.1038/s41598-021-04349-7
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Pessoa-Amorim, G., Staplin, N., Emberson, J. R., Campbell, M., Spata, E., . . . Landray, M. J. (2022). Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. LANCET, 399(10320), 143-151. doi:10.1016/S0140-6736(21)01825-0
Doravirine: its role in HIV treatment
Stockdale, A., & Khoo, S. (2022). Doravirine: its role in HIV treatment. Current Opinion in HIV and AIDS.
2021
Late presentation of hepatocellular carcinoma highlights the need for a public health programme to eliminate hepatitis B
Nhlane, R., Kreuels, B., Mallewa, J., Chetcuti, K., Gordon, M. A., & Stockdale, A. J. (2021). Late presentation of hepatocellular carcinoma highlights the need for a public health programme to eliminate hepatitis B. LANCET, 398(10318), 2288. Retrieved from https://www.webofscience.com/
Parallel Sessions
Parallel Sessions (2021). Journal of Hepatology, 75, S205-S293. doi:10.1016/s0168-8278(21)01842-0
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Horby, P. W., Landray, M. J., & Grp, R. E. C. O. V. E. R. Y. C. (2021). Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. LANCET, 397(10289), 2049-2059. doi:10.1016/S0140-6736(21)00897-7
Diagnostic performance evaluation of hepatitis B e antigen rapid diagnostic tests in Malawi
Stockdale, A. J., Silungwe, N. M., Shawa, I. T., Kreuels, B., Gordon, M. A., & Geretti, A. M. (2021). Diagnostic performance evaluation of hepatitis B e antigen rapid diagnostic tests in Malawi. BMC INFECTIOUS DISEASES, 21(1), 10 pages. doi:10.1186/s12879-021-06134-3
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., & Landray, M. J. (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. LANCET, 397(10285), 1637-1645. Retrieved from https://www.webofscience.com/
Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard: Clinical sensitivity of SARS-CoV-2 PCR.
Stockdale, A. J., Fyles, F., Farrell, C., Lewis, J., Barr, D., Haigh, K., . . . Joekes, E. (2021). Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard: Clinical sensitivity of SARS-CoV-2 PCR.. The Journal of infection. doi:10.1016/j.jinf.2021.04.012
Erratum to "Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome"
Lee, R. J., Wysocki, O., Bhogal, T., Shotton, R., Tivey, A., Angelakas, A., . . . Armstrong, A. C. (2021). Erratum to "Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome". ESMO OPEN, 6(2). doi:10.1016/j.esmoop.2021.100056
Dexamethasone in Hospitalized Patients with Covid-19
Wootton, D., & The RECOVERY Collaborative Group. (2021). Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine, 384(8), 693-704. doi:10.1056/nejmoa2021436
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Roddick, A., Spata, E., Staplin, N., Emberson, J., Pessoa-Amorim, G., . . . Yates, H. (2021). Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. LANCET, 397(10274), 605-612. doi:10.1016/S0140-6736(21)00149-5
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome
Lee, R. J., Wysocki, O., Bhogal, T., Shotton, R., Tivey, A., Angelakas, A., . . . Armstrong, A. C. (2021). Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome. ESMO OPEN, 6(1), 12 pages. doi:10.1016/j.esmoop.2020.100005
Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.
Bhogal, T., Khan, U. T., Lee, R., Stockdale, A., Hesford, C., Potti-Dhananjaya, V., . . . Palmieri, C. (2021). Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.. Leukemia & lymphoma, 1-16. doi:10.1080/10428194.2021.1876865
2020
Establishment of CORONET; COVID-19 Risk in Oncology Evaluation Tool to identify cancer patients at low versus high risk of severe complications of COVID-19 infection upon presentation to hospital
Lee, R. J., Zhou, C., Wysocki, O., Shotton, R., Tivey, A., Lever, L., . . . Armstrong, A. C. (2020). Establishment of CORONET; COVID-19 Risk in Oncology Evaluation Tool to identify cancer patients at low versus high risk of severe complications of COVID-19 infection upon presentation to hospital. doi:10.1101/2020.11.30.20239095
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Horby, P., Mafham, M., Linsell, L., Bell, J. L., Staplin, N., Emberson, J. R., . . . Landray, M. J. (2020). Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. NEW ENGLAND JOURNAL OF MEDICINE, 383(21), 2030-2040. doi:10.1056/NEJMoa2022926
Reply to: "Revisiting the estimation of hepatitis D global prevalence"
Stockdale, A. J., Hutin, Y., & Geretti, A. M. (2020). Reply to: "Revisiting the estimation of hepatitis D global prevalence". JOURNAL OF HEPATOLOGY, 73(5), 1280-1281. doi:10.1016/j.jhep.2020.06.039
Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study.
Geretti, A. M., Stockdale, A. J., Kelly, S. H., Cevik, M., Collins, S., Waters, L., . . . Semple, M. G. (2020). Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. doi:10.1093/cid/ciaa1605
The global prevalence of hepatitis D virus infection: systematic review and meta-analysis
Stockdale, A. J., Kreuels, B., Henrion, M. Y. R., Giorgi, E., Kyomuhangi, I., de Martel, C., . . . Geretti, A. M. (2020). The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. Journal of Hepatology. doi:10.1016/j.jhep.2020.04.008
Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol (UK): a prospective observational study
Geretti, A., Stockdale, A., Kelly, S., Villa, G., Turtle, L., Semple, M., & Sabin, C. (2020). Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol (UK): a prospective observational study. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 23, 13-14. Retrieved from https://www.webofscience.com/
Evaluation of hepatitis B virus (HBV) epidemiology, vaccine impact and treatment eligibility: a census-based community serological survey in Blantyre, Malawi
Stockdale, A., Meiring, J., Shawa, I. T., Thindwa, D., Silungwe, N., Mbewe, M., . . . Gordon, M. (2020). Evaluation of hepatitis B virus (HBV) epidemiology, vaccine impact and treatment eligibility: a census-based community serological survey in Blantyre, Malawi. In JOURNAL OF HEPATOLOGY Vol. 73 (pp. S790). Retrieved from https://www.webofscience.com/
SAT274 Evaluation of hepatitis B virus (HBV) epidemiology, vaccine impact and treatment eligibility: a census-based community serological survey in Blantyre, Malawi
Stockdale, A., Meiring, J., Shawa, I. T., Thindwa, D., Silungwe, N., Mbewe, M., . . . Gordon, M. (2020). SAT274 Evaluation of hepatitis B virus (HBV) epidemiology, vaccine impact and treatment eligibility: a census-based community serological survey in Blantyre, Malawi. In Journal of Hepatology Vol. 73 (pp. s790). Elsevier. doi:10.1016/s0168-8278(20)32027-4
Hepatitis B and C in Malawi: Epidemiology, Disease Burden and Opportunities for a Public Health Treatment Programme
Stockdale, A. (2020, March 20). Hepatitis B and C in Malawi: Epidemiology, Disease Burden and Opportunities for a Public Health Treatment Programme.
Hepatitis D prevalence: problems with extrapolation to global population estimates
Stockdale, A. J., Kreuels, B., Henrion, M. R. Y., Giorgi, E., Kyomuhangi, I., & Geretti, A. M. (2020). Hepatitis D prevalence: problems with extrapolation to global population estimates. GUT, 69(2), 396-+. doi:10.1136/gutjnl-2018-317874
Outcomes of COVID-19 Related Hospitalisation Among People with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: Prospective Observational Study
Geretti, A. M., Stockdale, A., Kelly, S., Cevik, M., Collins, S., Waters, L., . . . Group, C. H. A. S. E. S. (2020). Outcomes of COVID-19 Related Hospitalisation Among People with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: Prospective Observational Study. doi:10.2139/ssrn.3666248
2019
EPIDEMIOLOGY OF HEPATITIS B AND EVALUATION OF VACCINE EFFICACY IN A CENSUS-BASED COMMUNITY SEROSURVEY OF NDIRANDE TOWNSHIP IN BLANTYRE, MALAWI
Stockdale, A. J., Shawa, I., Everett, D., Geretti, A. M., & Gordon, M. (2019). EPIDEMIOLOGY OF HEPATITIS B AND EVALUATION OF VACCINE EFFICACY IN A CENSUS-BASED COMMUNITY SEROSURVEY OF NDIRANDE TOWNSHIP IN BLANTYRE, MALAWI. In TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE Vol. 113 (pp. S225-S226). Retrieved from https://www.webofscience.com/
2018
Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring
Villa, G., Phillips, R. O., Smith, C., Stockdale, A. J., Ruggiero, A., Beloukas, A., . . . Geretti, A. M. (2018). Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73(11), 3148-3157. doi:10.1093/jac/dky281
Epidemiology of hepatitis B, C and D in Malawi: systematic review
Stockdale, A. J., Mitambo, C., Everett, D., Geretti, A. M., & Gordon, M. A. (2018). Epidemiology of hepatitis B, C and D in Malawi: systematic review. BMC INFECTIOUS DISEASES, 18, 10 pages. doi:10.1186/s12879-018-3428-7
Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor–Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis
Stockdale, A. J., Saunders, M. J., Boyd, M. A., Bonnett, L. J., Johnston, V., Wandeler, G., . . . Geretti, A. M. (2018). Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor–Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis. Clinical Infectious Diseases, 66(12), 1846-1857. doi:10.1093/cid/cix1108
Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana
Villa, G., Phillips, R. O., Smith, C., Stockdale, A. J., Beloukas, A., Appiah, L. T., . . . Geretti, A. M. (2018). Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana. JOURNAL OF INFECTION, 76(6), 515-521. doi:10.1016/j.jinf.2018.03.001
Correction to Lancet Glob Health 2018; 6: e34.
Correction to Lancet Glob Health 2018; 6: e34. (2018). The Lancet. Global health, 6(2), e151. doi:10.1016/s2214-109x(18)30010-x
Epidemiological data for hepatitis D in Africa
Stockdale, A. J., Beloukas, A., & Gerretti, A. M. (2018). Epidemiological data for hepatitis D in Africa. LANCET GLOBAL HEALTH, 6(1), E34. Retrieved from http://gateway.webofknowledge.com/
Epidemiological data for hepatitis D in Africa. Author's reply (vol 6, pg e34, 2018)
Stockdale, A. J., Beloukas, A., & Geretti, A. M. (2018). Epidemiological data for hepatitis D in Africa. Author's reply (vol 6, pg e34, 2018). LANCET GLOBAL HEALTH, 6(2), E151. doi:10.1016/S2214-109X(18)30010-X
2017
Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis (vol 5, pg e992, 2016)
Stockdale, A. J., Chaponda, M., & Beloukas, A. (2017). Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis (vol 5, pg e992, 2016). LANCET GLOBAL HEALTH, 5(11), E1079. doi:10.1016/S2214-109X(17)30381-9
Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis
Stockdale, A. J., Chaponda, M., Beloukas, A., Phillips, R. O., Matthews, P. C., Papadimitropoulos, A., . . . Geretti, A. M. (2017). Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Global Health, 5(10), E992-E1003. doi:10.1016/S2214-109X(17)30298-X
Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions
Lord, E., Stockdale, A. J., Malek, R., Rae, C., Sperle, I., Raben, D., . . . Sullivan, A. K. (2017). Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions. HIV MEDICINE, 18(4), 300-304. doi:10.1111/hiv.12430
2016
Long- term virological outcomes of replacing zidovudine or stavudine with tenofovir in the absence of routine virological monitoring in Kumasi, Ghana
Villa, G., Phillips, R. O., Smith, C., Stockdale, A., Beloukas, A., Appiah, L. T., . . . Geretti, A. M. (2016). Long- term virological outcomes of replacing zidovudine or stavudine with tenofovir in the absence of routine virological monitoring in Kumasi, Ghana. In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY Vol. 19. Retrieved from http://gateway.webofknowledge.com/
Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV co-infected individuals in Sub-Saharan Africa: results from the HEPIK cohort
Villa, G., Phillips, R. O., Smith, C., Stockdale, A., Beloukas, A., Appiah, L. T., . . . Geretti, A. M. (2016). Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV co-infected individuals in Sub-Saharan Africa: results from the HEPIK cohort. In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY Vol. 19 (pp. 1 page). Retrieved from https://www.webofscience.com/
Liver stiffness and virologic outcomes after introducing tenofovir as part of antiretroviral therapy in lamivudine-experienced adults with HIV and hepatitis B virus (HBV) co-infection in Ghana: four-year follow up of the prospective HEPIK cohort
Stockdale, A., Phillips, R. O., Sarfo, F. S., Appiah, L. T., Bonnett, L. J., Chadwicks, D., . . . Geretti, A. M. (2016). Liver stiffness and virologic outcomes after introducing tenofovir as part of antiretroviral therapy in lamivudine-experienced adults with HIV and hepatitis B virus (HBV) co-infection in Ghana: four-year follow up of the prospective HEPIK cohort. In HEPATOLOGY Vol. 64 (pp. abstract 1905). Retrieved from https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.28800
The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa' by Lemoine <i>et al</i>
Stockdale, A. J., Phillips, R. O., & Geretti, A. M. (2016). The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa' by Lemoine <i>et al</i>. GUT, 65(5), 882-U193. doi:10.1136/gutjnl-2015-311133
Emergence of extensive fluoroquinolone resistance in <i>Campylobacter</i> gastroenteritis in Liverpool, UK
Stockdale, A. J., Beeching, N. J., Anson, J., & Beadsworth, M. B. J. (2016). Emergence of extensive fluoroquinolone resistance in <i>Campylobacter</i> gastroenteritis in Liverpool, UK. JOURNAL OF INFECTION, 72(3), 398-400. doi:10.1016/j.jinf.2015.12.004
More Long-term Assessment of Transient Elastography Is Needed for HIV/Hepatitis B Virus-Coinfected Patients Undergoing Treatment With Tenofovir Reply
Stockdale, A. J., & Geretti, A. M. (2016). More Long-term Assessment of Transient Elastography Is Needed for HIV/Hepatitis B Virus-Coinfected Patients Undergoing Treatment With Tenofovir Reply. CLINICAL INFECTIOUS DISEASES, 62(1), 130-+. doi:10.1093/cid/civ768
2015
Liver fibrosis by transient elastography and virologic outcomes after introduction of tenofovir in lamivudine-experienced adults with HIV and hepatitis B virus (HBV) co-infection in Ghana
Stockdale, A., Phillips, R. O., Beloukas, A., Appiah, L. T., Chadwick, D., Bhagani, S., . . . Geretti, A. (2015). Liver fibrosis by transient elastography and virologic outcomes after introduction of tenofovir in lamivudine-experienced adults with HIV and hepatitis B virus (HBV) co-infection in Ghana. Clinical Infectious Diseases, 61(6), 883-891. doi:10.1093/cid/civ421
Chronic hepatitis B infection in sub-Saharan Africa: a grave challenge and a great hope
Stockdale, A. J., & Geretti, A. M. (2015). Chronic hepatitis B infection in sub-Saharan Africa: a grave challenge and a great hope. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 109(7), 421-422. doi:10.1093/trstmh/trv044
Do UK specialty guidelines recommend testing for HIV indicator diseases?
Stockdale, A., Byrne, L., Curtis, H., Duncan, C., Lord, E., Malek, R., . . . Sullivan, A. (2015). Do UK specialty guidelines recommend testing for HIV indicator diseases?. In HIV MEDICINE Vol. 16 (pp. 48). Retrieved from https://www.webofscience.com/
2014
A Granulomatous Chronic Disease
Helgason, K. O., Med, C., & Chir. (2014). A Granulomatous Chronic Disease. AMERICAN JOURNAL OF MEDICINE, 127(5), E5-E6. doi:10.1016/j.amjmed.2013.12.012
HIV and hepatitis B virus (HBV) outcomes after switching stavudine or zidovudine to tenofovir in subjects receiving first-line antiretroviral therapy (ART) in Ghana
Geretti, A. M., Stockdale, A., Appiah, L., Beloukas, A., Adinku, D., Chadwick, D., . . . Phillips, R. O. (2014). HIV and hepatitis B virus (HBV) outcomes after switching stavudine or zidovudine to tenofovir in subjects receiving first-line antiretroviral therapy (ART) in Ghana. In ANTIVIRAL THERAPY Vol. 19 (pp. A37). Retrieved from https://www.webofscience.com/
2013
Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study
Stockdale, A. J., Nkuranga, J., Toeroek, M. E., Faragher, B., & Lalloo, D. G. (2013). Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 18(7), 907-914. doi:10.1111/tmi.12110
2011
Case Report: Severe Typhus Group Rickettsiosis Complicated by Pulmonary Edema in a Returning Traveler from Indonesia
Stockdale, A. J., Weekes, M. P., Kiely, B., & Lever, A. M. L. (2011). Case Report: Severe Typhus Group Rickettsiosis Complicated by Pulmonary Edema in a Returning Traveler from Indonesia. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 85(6), 1121-1123. doi:10.4269/ajtmh.2011.11-0340
An audit of acute bacterial meningitis in a large teaching hospital 2005-10
Stockdale, A. J., Weekes, M. P., & Aliyu, S. H. (2011). An audit of acute bacterial meningitis in a large teaching hospital 2005-10. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 104(12), 1055-1063. doi:10.1093/qjmed/hcr123
2010
Evidence behind the WHO guidelines: Hospital Care for Children: What is the Diagnostic Accuracy of Gastric Aspiration for the Diagnosis of Tuberculosis in Children?
Stockdale, A. J., Duke, T., Graham, S., & Kelly, J. (2010). Evidence behind the WHO guidelines: Hospital Care for Children: What is the Diagnostic Accuracy of Gastric Aspiration for the Diagnosis of Tuberculosis in Children?. JOURNAL OF TROPICAL PEDIATRICS, 56(5), 291-298. doi:10.1093/tropej/fmq081
1999
Waiting for the cure: mapping the social relations of human gene therapy research
Stockdale, A. (1999). Waiting for the cure: mapping the social relations of human gene therapy research. SOCIOLOGY OF HEALTH & ILLNESS, 21(5), 579-596. doi:10.1111/1467-9566.00174